von Borstel & Associates Inc. purchased a new stake in shares of The Procter & Gamble Company (NYSE:PG – Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 1,575 shares of the company’s stock, valued at approximately $272,000.
Several other institutional investors and hedge funds also recently bought and sold shares of the business. Itau Unibanco Holding S.A. purchased a new stake in Procter & Gamble in the second quarter worth approximately $28,000. Fairway Wealth LLC bought a new position in shares of Procter & Gamble during the second quarter valued at about $29,000. Ruedi Wealth Management Inc. increased its holdings in shares of Procter & Gamble by 64.7% in the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after buying an additional 77 shares during the period. POM Investment Strategies LLC bought a new stake in shares of Procter & Gamble in the 2nd quarter valued at about $34,000. Finally, Quest Partners LLC purchased a new stake in shares of Procter & Gamble during the second quarter valued at approximately $36,000. 65.77% of the stock is owned by institutional investors.
Analysts Set New Price Targets
Several research firms have recently issued reports on PG. BNP Paribas started coverage on Procter & Gamble in a research note on Monday, June 24th. They set an “outperform” rating and a $187.00 target price on the stock. Royal Bank of Canada lifted their price target on Procter & Gamble from $157.00 to $164.00 and gave the stock a “sector perform” rating in a research report on Wednesday, July 31st. Barclays cut Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target on the stock. in a report on Monday, September 30th. Dbs Bank downgraded Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 1st. Finally, Wolfe Research upgraded shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, August 23rd. Nine equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus target price of $176.21.
Insider Buying and Selling at Procter & Gamble
In other news, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the sale, the insider now owns 11,537 shares in the company, valued at approximately $1,902,451.30. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Procter & Gamble news, insider Balaji Purushothaman sold 8,842 shares of the firm’s stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the sale, the insider now owns 11,537 shares in the company, valued at approximately $1,902,451.30. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Susan Street Whaley sold 450 shares of the stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total transaction of $76,149.00. Following the completion of the transaction, the insider now owns 13,072 shares of the company’s stock, valued at $2,212,043.84. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 383,194 shares of company stock valued at $65,140,718 over the last ninety days. Corporate insiders own 0.17% of the company’s stock.
Procter & Gamble Stock Performance
NYSE PG traded up $0.79 on Tuesday, reaching $173.30. The stock had a trading volume of 4,199,863 shares, compared to its average volume of 6,670,587. The stock has a market cap of $409.01 billion, a P/E ratio of 28.43, a price-to-earnings-growth ratio of 3.67 and a beta of 0.41. The Procter & Gamble Company has a 12-month low of $142.50 and a 12-month high of $177.94. The business’s 50-day moving average price is $171.57 and its 200 day moving average price is $166.88. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.53 and a current ratio of 0.73.
Procter & Gamble (NYSE:PG – Get Free Report) last released its quarterly earnings data on Tuesday, July 30th. The company reported $1.40 earnings per share for the quarter, beating the consensus estimate of $1.37 by $0.03. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The firm had revenue of $20.53 billion during the quarter, compared to the consensus estimate of $20.69 billion. During the same period last year, the business posted $1.37 EPS. Procter & Gamble’s quarterly revenue was down .1% on a year-over-year basis. As a group, equities analysts expect that The Procter & Gamble Company will post 6.97 earnings per share for the current year.
Procter & Gamble Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.32%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s dividend payout ratio is currently 65.69%.
About Procter & Gamble
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Articles
- Five stocks we like better than Procter & Gamble
- Investing in Commodities: What Are They? How to Invest in Them
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- Utilities Stocks Explained – How and Why to Invest in Utilities
- AMD Gains Momentum With AI: Can It Beat Expectations?
- What Are Trending Stocks? Trending Stocks Explained
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.